1. Home
  2. GRWG vs IVA Comparison

GRWG vs IVA Comparison

Compare GRWG & IVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GrowGeneration Corp.

GRWG

GrowGeneration Corp.

HOLD

Current Price

$1.60

Market Cap

96.7M

ML Signal

HOLD

Logo Inventiva S.A. American Depository Shares

IVA

Inventiva S.A. American Depository Shares

HOLD

Current Price

$5.40

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRWG
IVA
Founded
2008
2011
Country
United States
France
Employees
253
77
Industry
RETAIL: Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
96.7M
1.1B
IPO Year
2015
N/A

Fundamental Metrics

Financial Performance
Metric
GRWG
IVA
Price
$1.60
$5.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
10
Target Price
$2.50
$16.20
AVG Volume (30 Days)
751.8K
254.3K
Earning Date
05-08-2026
03-30-2026
Dividend Yield
N/A
N/A
EPS Growth
51.22
N/A
EPS
N/A
N/A
Revenue
$193,365,479.00
N/A
Revenue This Year
$5.09
N/A
Revenue Next Year
N/A
$751.20
P/E Ratio
N/A
N/A
Revenue Growth
142.51
N/A
52 Week Low
$0.93
$2.94
52 Week High
$2.40
$7.98

Technical Indicators

Market Signals
Indicator
GRWG
IVA
Relative Strength Index (RSI) 69.91 48.36
Support Level $1.44 $4.98
Resistance Level $1.82 $6.42
Average True Range (ATR) 0.09 0.24
MACD 0.02 0.05
Stochastic Oscillator 98.89 44.54

Price Performance

Historical Comparison
GRWG
IVA

About GRWG GrowGeneration Corp.

GrowGeneration Corp owns and operates specialty retail stores focused on hydroponic and organic gardening. The company markets and distributes nutrients, growing media, indoor and greenhouse lighting, ventilation systems, and related accessories. It operates through two reportable segments: Cultivation and Gardening, which includes its hydroponic and organic gardening business, and Storage Solutions, which includes its benching, racking, and storage solutions operations. The company generates revenue mainly from the sale of proprietary and non-proprietary products through retail stores, e-commerce platforms, wholesale distribution, and commercial sales, along with the sale and installation of commercial fixtures.

About IVA Inventiva S.A. American Depository Shares

Inventiva SA is a France-based biopharmaceutical company specialized in developing drugs that impact on nuclear receptors, transcription factors and epigenetic modulation. The company is focused on developing its product candidate, lanifibranor, for the treatment of patients with non-alcoholic steatohepatitis, or NASH, a disease for which there are currently no approved therapies. The company is also involved in developing a portfolio of pre-clinical therapy programs. It operates in the segment of Service delivery and clinical stage research, notably into therapies in the areas of oncology, fibrosis, and rare diseases. All the company's operations are in France. Majority of the group's revenue is derived from its research partnerships with AbbVie and BI.

Share on Social Networks: